(2023) 44:ehad192
Your provider reviews your health history, symptoms, wellness goals, medications, and treatment eligibility
Our latest article discusses the potential connection between the GLP-1 drug, Wegovy, and panic attacks
Palmitoylethanolamide (PEA), an endogenous lipid mediator with well-documented anti-inflammatory and neuroprotective effects, has also shown promise in post-viral fatigue and neuroinflammatory conditions
Several trials have demonstrated that GLP-1 RAs reduce cardiovascular risk in patients with type 2 diabetes mellitus and ASCVD or high cardiovascular risk and have beneficial effects on cardio-renal outcomes beyond their blood glucose-lowering effects in type 2 diabetes mellitus patients
The renal injury parameters including 24-h urinary protein, blood urea nitrogen and serum creatinine were assessed